Andrx, Schering Settle Claritin-D Patent Dispute

Law360, New York (October 24, 2003, 12:00 AM EDT) -- Andrx Corp. settled a patent dispute with Schering-Plough Corp. over Andrx's generic version of the Claritin-D 24-hour allergy medicine, the companies said Friday.

Andrx will receive a license to a patent for the drug from Schering-Plough, the company said. Andrx said that the lawsuit would be dismissed, but did not disclose financial terms of the settlement.

Andrx's generic Claritin-D 24 is marketed by Perrigo Company as an over-the-counter product used for the relief of symptoms of seasonal allergic rhinitis, commonly known as hay fever, the company...
To view the full article, register now.